Concord Wealth Partners’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,000
| Closed | -$13K | – | 1268 |
|
|
2022
Q4 | $13K | Buy |
11,000
+1,000
| +10% | +$1.18K | ﹤0.01% | 600 |
|
|
2022
Q3 | $20K | Buy |
10,000
+3,000
| +43% | +$6K | 0.01% | 159 |
|
|
2022
Q2 | $11K | Buy |
7,000
+2,000
| +40% | +$3.14K | ﹤0.01% | 679 |
|
|
2022
Q1 | $25K | Buy |
5,000
+4,000
| +400% | +$20K | 0.01% | 592 |
|
|
2021
Q4 | $6K | Buy |
+1,000
| New | +$6K | ﹤0.01% | 921 |
|